{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:10:13Z","timestamp":1784002213720,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011033","name":"Thermo Fisher Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.xagr.2023.100193","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T21:14:43Z","timestamp":1678482883000},"page":"100193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy\u2013associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1\u2013placental growth factor ratio in the early second trimester"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-2638","authenticated-orcid":false,"given":"Tianhua","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamim","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Priston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evasha","family":"Rasasakaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Mak-Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Mei-Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Melanie","family":"Bedford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl1","key":"10.1016\/j.xagr.2023.100193_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.xagr.2023.100193_bib0002","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/bmj.38629.587639.7C","article-title":"Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study","volume":"331","author":"Gardosi","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.xagr.2023.100193_bib0003","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0002-9378(98)70544-7","article-title":"The preterm prediction study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network","volume":"178","author":"Iams","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.09.041","article-title":"Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population","volume":"221","author":"Chaemsaithong","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000362518","article-title":"Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeks\u2019 gestation","volume":"36","author":"Larroca","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.xagr.2023.100193_bib0007","series-title":"NICE recommends four tests to help diagnose pre-eclampsia. BMJ","year":"2022"},{"key":"10.1016\/j.xagr.2023.100193_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/uog.21869","article-title":"From first-trimester screening to risk stratification of evolving pre-eclampsia in the second and third trimesters of pregnancy: comprehensive approach","volume":"55","author":"Poon","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0009","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12884-022-04514-4","article-title":"Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.xagr.2023.100193_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0011","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0012","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jogc.2017.07.014","article-title":"First and second trimester serum sFlt-1\/PlGF ratio and subsequent preeclampsia: a systematic review","volume":"40","author":"Yusuf","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.xagr.2023.100193_bib0013","first-page":"18","article-title":"PlGF, sFlt-1 and sFlt-1\/PlGF ratio: promising markers for predicting pre-eclampsia","volume":"4","author":"El-Demerdash","year":"2018","journal-title":"J Gynecol Res Obstet"},{"key":"10.1016\/j.xagr.2023.100193_bib0014","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/diagnostics9030094","article-title":"Comparison of procalcitonin assays on KRYPTOR and LIAISON\u00ae XL analyzers","volume":"9","author":"Dipalo","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.xagr.2023.100193_bib0015","unstructured":"ThermoFisher. TRACE \u2013 Powerful Technology. 2022. Available at: https:\/\/www.brahms.de\/en-gb\/products\/kryptor-analyzers\/trace-technology.html. Accessed March 24, 2023."},{"key":"10.1016\/j.xagr.2023.100193_bib0016","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2393-13-110","article-title":"Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort","volume":"13","author":"Villa","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.xagr.2023.100193_bib0017","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.xagr.2023.100193_bib0018","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pd.2660","article-title":"Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks","volume":"31","author":"Akolekar","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.xagr.2023.100193_bib0019","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xagr.2023.100193_bib0022","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/labmed\/lmx076","article-title":"The new possibilities in early diagnosis of preeclampsia by soluble fms-like tyrosine Kinase-1 and placental growth factor in 16-20 weeks gestation","volume":"49","author":"Benovsk\u00e1","year":"2018","journal-title":"Lab Med"},{"key":"10.1016\/j.xagr.2023.100193_bib0023","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/uog.17373","article-title":"sFlt-1\/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain)","volume":"50","author":"Perales","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0024","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.preghy.2019.03.009","article-title":"Midpregnancy prediction of pre-eclampsia using serum biomarkers sFlt-1 and PlGF","volume":"16","author":"Black","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.xagr.2023.100193_bib0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/uog.15750","article-title":"Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia","volume":"47","author":"Khalil","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0026","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10641955.2020.1745227","article-title":"Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida","volume":"39","author":"Phupong","year":"2020","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.xagr.2023.100193_bib0027","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/uog.17301","article-title":"Screening for pre-eclampsia using sFlt-1\/PlGF ratio cut-off of 38 at 30-37 weeks\u2019 gestation","volume":"49","author":"Dragan","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0028","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","article-title":"Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in Asian women with suspected preeclampsia","volume":"74","author":"Bian","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.xagr.2023.100193_bib0029","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.xagr.2023.100193_bib0030","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xagr.2023.100193_bib0031","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/1471-0528.12128","article-title":"Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?","volume":"120","author":"Myatt","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.xagr.2023.100193_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.10.909","article-title":"Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia","volume":"196","author":"Vatten","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2023.100193_bib0033","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"Erez","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.xagr.2023.100193_bib0034","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/jhh.2013.148","article-title":"Is ethnicity a risk factor for developing preeclampsia? An analysis of the prevalence of preeclampsia in China","volume":"28","author":"Xiao","year":"2014","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.xagr.2023.100193_bib0035","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2021.22749","article-title":"Aspirin use for preeclampsia prevention among women with prepregnancy diabetes, obesity, and hypertension","volume":"327","author":"Ray","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.xagr.2023.100193_bib0036","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jogc.2017.04.040","article-title":"Low rates of aspirin use for the prevention of preeclampsia","volume":"39","author":"Viguiliouk","year":"2017","journal-title":"J Obstet Gynaecol Can"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577823000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577823000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:20:31Z","timestamp":1763000431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577823000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2666577823000345"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2023.100193","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy\u2013associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1\u2013placental growth factor ratio in the early second trimester","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2023.100193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100193"}}